Clinical trial
Stage I/II NSCLC Perioperative Chemotherapy
NCT00198354 · Intergroupe Francophone de Cancerologie Thoracique, Other · Completed
Key facts
| NCT number | NCT00198354 |
|---|---|
| Title | Stage I/II NSCLC Perioperative Chemotherapy |
| Official title | Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC |
| Lead sponsor | Intergroupe Francophone de Cancerologie Thoracique, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer Stage I and II, Peri-operative Chemotherapy |
| Intervention type | Drug |
| Interventions | gemcitabine + cisplatine, Paclitaxel + Carboplatine |
| Enrollment | 530 |
| Start date | May 1, 2001 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 10, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: